Literature DB >> 8607522

Lymphoepithelioma-like carcinoma of the rectum in a patient with ulcerative colitis.

J P Palazzo1, K R Mittal.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8607522

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  6 in total

1.  HPV-16-associated lymphoepithelial-like carcinoma mimicking rectal tonsil.

Authors:  Pallavi Kopparthy; Joanna Chaffin; Michael M Feely; Hiral D Parekh
Journal:  Clin J Gastroenterol       Date:  2021-02-19

2.  A case of lymphoepithelioma-like carcinoma of the colon with ulcerative colitis.

Authors:  Yasuyuki Kojima; Masatoshi Mogaki; Ryo Takagawa; Ikuko Ota; Mitsutaka Sugita; Shiho Natori; Yohei Hamaguchi; Haruki Kurosawa; Tadao Fukushima; Hidenobu Masui; Shingo Fukazawa; Shoji Yamanaka; Yukio Tsuura; Kaoru Nagahori
Journal:  J Gastroenterol       Date:  2007-03-12       Impact factor: 7.527

3.  A case of Lymphoepithelioma-like carcinoma (LELC) developed in the rectum.

Authors:  Haruka Oi; Satoshi Yamamoto; Yoshiharu Kono; Yukiyoshi Masaki
Journal:  Rep Pract Oncol Radiother       Date:  2019-10-29

Review 4.  Microscopic features of colorectal neoplasia in inflammatory bowel diseases.

Authors:  Aude Bressenot; Virginie Cahn; Silvio Danese; Laurent Peyrin-Biroulet
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

5.  A case of poorly differentiated adenocarcinoma with lymphoid stroma originated in the ascending colon diagnosed as lymphoepithelioma-like carcinoma.

Authors:  Kengo Kai; Hideki Hidaka; Takeshi Nakamura; Yuji Ueda; Kosuke Marutsuka; Takuto Ikeda; Atsushi Nanashima
Journal:  Clin J Gastroenterol       Date:  2019-12-16

6.  A Rare Case of Moderately Differentiated Adenocarcinoma With PD-L1 Overexpression and a Heterogeneous LELC Component in the Ascending Colon.

Authors:  Hideki Nagano; Takeshi Watanabe; Tamotsu Togawa; Kenji Ohnishi; Toshihisa Kimura; Atsushi Iida; Yasunori Sato; Takanori Goi
Journal:  Onco Targets Ther       Date:  2020-01-28       Impact factor: 4.147
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.